Companies / REGENXBIO Inc. / Activity
Activity — REGENXBIO Inc.
26 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Mills Kenneth T. Director | Other | Common Stock | $2.97M | -222K -31.33% | 486,118 0.74% of shares | low |
| Jan 27, 2026 | Mills Kenneth T. Director | Exercise | Common Stock | $2.95M | +225K +46.60% | 707,871 1.07% of shares | low |
| Jan 2, 2026 | Simpson Curran CEO | Other | Common Stock | $267.2K | -19K -8.59% | 197,603 0.30% of shares | low |
| Jan 2, 2026 | Pakola Steve Executive | Other | Common Stock | $262.8K | -18K -8.66% | 192,470 0.29% of shares | low |
| Jan 2, 2026 | Christmas Patrick J. Executive | Other | Common Stock | $141.0K | -10K -6.47% | 141,618 0.21% of shares | low |
| Feb 1, 2026 | Pakola Steve Executive | Other | Common Stock | $58.8K | -5K -2.04% | 253,050 0.38% of shares | low |
| Mar 10, 2026 | Pakola Steve Executive | Sell | Common Stock | $53.0K | -5K -2.02% | 247,926 0.38% of shares | low |
| Feb 1, 2026 | Christmas Patrick J. Executive | Other | Common Stock | $52.5K | -5K -2.18% | 210,667 0.32% of shares | low |
| Jan 2, 2026 | Malzahn Craig Executive | Other | Common Stock | $17.8K | -1K -7.04% | 16,347 0.02% of shares | low |
| May 29, 2026 | Stump David C Director | Grant | Common Stock | $0 | +10K +51.47% | 28,861 0.04% of shares | low |
| May 29, 2026 | Karabelas Argeris N Director | Grant | Common Stock | $0 | +10K +51.47% | 28,861 0.04% of shares | low |
| May 29, 2026 | Migausky George V Director | Grant | Common Stock | $0 | +10K +51.47% | 28,861 0.04% of shares | low |
| Jan 6, 2026 | Chan Mitchell Executive | Grant | Common Stock | $0 | +74K +136.65% | 127,717 0.19% of shares | low |
| Jan 6, 2026 | Pakola Steve Executive | Grant | Common Stock | $0 | +66K +34.21% | 258,317 0.39% of shares | low |
| Jan 6, 2026 | Malzahn Craig Executive | Grant | Common Stock | $0 | +66K +402.81% | 82,194 0.12% of shares | low |
| Jan 6, 2026 | Christmas Patrick J. Executive | Grant | Common Stock | $0 | +74K +52.08% | 215,367 0.33% of shares | low |
| Jan 6, 2026 | Simpson Curran CEO | Grant | Common Stock | $0 | +145K +73.31% | 342,467 0.52% of shares | low |
| May 29, 2026 | Stump David C Director | Grant | Stock Options (Right to Buy) | — | +47K | 46,600 0.07% of shares | low |
| May 29, 2026 | Karabelas Argeris N Director | Grant | Stock Options (Right to Buy) | — | +47K | 46,600 0.07% of shares | low |
| May 29, 2026 | Migausky George V Director | Grant | Stock Options (Right to Buy) | — | +47K | 46,600 0.07% of shares | low |
| Jan 6, 2026 | Chan Mitchell Executive | Grant | Stock Options (Right to buy) | — | +40K | 39,650 0.06% of shares | low |
| Jan 6, 2026 | Pakola Steve Executive | Grant | Stock Options (Right to buy) | — | +35K | 35,402 0.05% of shares | low |
| Jan 27, 2026 | Mills Kenneth T. Director | Exercise | Stock Options (Right to Buy) | — | -225K -50.00% | 225,000 0.34% of shares | low |
| Jan 6, 2026 | Malzahn Craig Executive | Grant | Stock Options (Right to buy) | — | +35K | 35,402 0.05% of shares | low |
| Jan 6, 2026 | Christmas Patrick J. Executive | Grant | Stock Options (Right to buy) | — | +40K | 39,650 0.06% of shares | low |
| Jan 6, 2026 | Simpson Curran CEO | Grant | Stock Options (Right to buy) | — | +234K | 233,651 0.35% of shares | low |